Innovation in Oligonucleotide Manufacture

Join us for the ​‘Innovation in Oligonucleotide Manufacture’ Symposium hosted by CPI’s Medicines Manufacturing Innovation Centre as we delve into the challenges and opportunities in the manufacturing of therapeutic oligonucleotides.

The pharmaceutical industry has an ever-growing interest in therapeutic oligonucleotides utilising a range of agents, including siRNA, antisense, and aptamers. This presents many challenges and opportunities for the manufacture of oligonucleotides, including capacity, scale, sustainability and cost. Current approaches rely on solid support-based synthesis, but the development of a range of alternative technologies offers opportunities to address some of the limitations of solid phase synthesis whilst also creating some new challenges. 

This symposium led by CPI’s Medicines Manufacturing Innovation Centre, intends to bring together key stakeholders from across the sector to highlight the emerging process technologies in the field and explore how those processes are best developed and exploited to drive successful manufacturing at scale. 

At the event, you will hear from a range of industry, academic, government and regulatory speakers who will also outline some of the key challenges such as targeted delivery and the balance between efficacy and efficiency. 

The conference will conclude with a panel discussion on the future of oligonucleotide therapeutics and will be followed by a networking reception.

Registration is now closed

Below you will find further information about the agenda, our sponsors, accommodation and directions to the venue.